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Abstract
Aims: Cardiac grafts from non-heartbeating donors (NHBDs) could significantly increase organ availability and reduce
waiting-list mortality. Reluctance to exploit hearts from NHBDs arises from obligatory delays in procurement leading to
periods of warm ischemia and possible subsequent contractile dysfunction. Means for early prediction of graft suitability
prior to transplantation are thus required for development of heart transplantation programs with NHBDs.
Methods and Results: Hearts (n = 31) isolated from male Wistar rats were perfused with modified Krebs-Henseleit buffer
aerobically for 20 min, followed by global, no-flow ischemia (32uC) for 30, 50, 55 or 60 min. Reperfusion was unloaded for
20 min, and then loaded, in working-mode, for 40 min. Left ventricular (LV) pressure was monitored using a micro-tip
pressure catheter introduced via the mitral valve. Several hemodynamic parameters measured during early, unloaded
reperfusion correlated significantly with LV work after 60 min reperfusion (p,0.001). Coronary flow and the production of
lactate and lactate dehydrogenase (LDH) also correlated significantly with outcomes after 60 min reperfusion (p,0.05).
Based on early reperfusion hemodynamic measures, a composite, weighted predictive parameter, incorporating heart rate
(HR), developed pressure (DP) and end-diastolic pressure, was generated and evaluated against the HR-DP product after
60 min of reperfusion. Effective discriminating ability for this novel parameter was observed for four HR*DP cut-off values,
particularly for $20 *103 mmHg*beats*min21 (p,0.01).
Conclusion: Upon reperfusion of a NHBD heart, early evaluation, at the time of organ procurement, of cardiac
hemodynamic parameters, as well as easily accessible markers of metabolism and necrosis seem to accurately predict
subsequent contractile recovery and could thus potentially be of use in guiding the decision of accepting the ischemic heart
for transplantation.
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Introduction
The discrepancy between supply and demand of donor organs
is currently a major challenge in heart transplantation and is
expected to worsen [1,2]. In recent years, this gap between supply
and demand has led to a renewed interest in non-heart-beating
donors (NHBDs) as a source of potential cardiac grafts. In fact,
NHBDs are already considered as an additional pool, alternative
to brain-dead donors, for various organs including kidneys, livers,
lungs and pancreatic islets. Although the first heart transplantation
was performed with a NHBD graft in 1967 [3], the use of NHBDs
hearts as a source of organs for cardiac transplantation was rapidly
discontinued as clear criteria of brain death were defined shortly
afterwards. Nevertheless, recent case reports have successfully
reconfirmed the feasibility of orthotopic transplantation of
NHBDs’ hearts in adult and pediatric patients [4,5]. As a matter
of fact, it was recently estimated that if hearts from NHBDs were
to be used for transplantation, the donor supply could increase up
to 17% in adults [6,7] and 42% in pediatric patients [8].
Use of NHBDs in the clinical setting of cardiac transplantation,
however, has not yet been adopted. This might be due, on one
hand, to good results obtained with an optimal myocardial
preservation strategy allowed by a coordinated organ procurement
protocol after brain death; and, on the other hand, to the
widespread belief that a period of warm ischemia always triggers
irreversible myocardial injury [5] and subsequent post-operative
contractile dysfunction. It is indeed true that NHBDs are legally
required to undergo a ‘‘hands-off’’ period, which results in a
period of warm ischemia of 2–10 min after cardiocirculatory
arrest, during which cardioprotective interventions are limited for
ethical reasons [9]. Several studies have clearly demonstrated,
however, that a normal heart preserves sufficient integrity for
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transplantation if warm ischemia is limited to 20–30 min
[10,11,12]. Therefore, a window of opportunity, albeit limited,
does exist for useable cardiac grafts from NHBDs and should most
probably be exploited, especially if reliable assessments could
predict mid- and long-term functional prognosis. This could be
even more advantageous if the window of opportunity could be
widened. In this sense, we were able to demonstrate in a previous
series of experiments, that functional recovery could be prolonged
to 50–55 minutes providing a slight reduction in heart tempera-
ture (32uC) was initiated immediately after cardio-circulatory
arrest (data not shown).
Heart evaluation is particularly important in the setting of
NHBDs; given that from one donor to another, conditions of
cardio-circulatory arrest and ischemic length and severity may
differ considerably, thereby leading to variable degrees of tissue
injury. Furthermore, not only ischemic injury, but also the chosen
reperfusion strategy, will affect the prognosis of a NHBD’s heart.
Consequently, and in order to consider this reperfusion injury,
evaluation of a NHBD’s heart should be performed after
reperfusion. Currently, only very few reports have proposed
potential evaluation methods to predict recovery of cardiac
contractile function applicable to NHBDs. These methods include
measurement of coronary flow [13,14], the use of an isolated
myocardial perfusion system [15,16] or fractional anisotropy [17],
however, the latter two approaches require highly specialized
equipment and considerable amounts of time.
In the current study, we aimed to simulate a NHBD setting in
order to investigate, during a brief period of unloaded reperfusion,
the potential of hemodynamic and biochemical markers that may
predict recovery, and therefore eligibility, of NHBD hearts for
cardiac transplantation. To do so, we chose to reduce the
temperature of the graft after onset of cardiac arrest since, as
previously mentioned, this might be a preliminary condition to
reduce the damage of NHBD hearts. By using this approach, we
also aimed to take advantage of a broader range of ischemic times,
enabling us to more precisely define the degree of post-ischemic
contractile recovery.
Methods
Materials
Bovine albumin (fraction V), palmitic acid and sodium-L-lactate
were purchased from Sigma-Aldrich (Buchs, Switzerland) and
insulin from Nordisk Pharma (Actrapid HM 100 IU/mL,
Ku¨snacht, Switzerland). All other chemicals were obtained from
Merck (Darmstadt, Germany). Dialysis membrane was purchased
from Spectrum Labs (Rancho Dominguez, USA).
Ethics Statement
All experimental procedures were performed in compliance
with the European Convention for Animal Care and approved by
the Swiss animal welfare authorities (Authorization Numbers: 58/
08 and 11/11). All surgery was performed under anesthesia and all
efforts were made to minimize suffering.
Isolated Heart Preparation
The experimental set-up consisted of a modified isolated rat
heart system as previously described [18]. Adult male Wistar rats
(n = 31, weighing 515653 g), fed on a standard laboratory diet ad
libitum, were anesthetized intraperitoneally using ketamine 1.3 mL/
g (Narketan, Vetoquinol AG, Bern) and xylazine 0.7 mL/g
(Xylapan, Vetoquinol AG, Bern). Hearts were then rapidly excised
and placed immediately in ice-cold, modified Krebs-Henseleit
bicarbonate (KHB) buffer containing (mM): NaCl 118, KCl 4.7,
KH2PO4 1.2, MgSO4N7H2O 1.2, CaCl2 (dihydrate) 1.25,
NaHCO3 25 and glucose 5.5 (Buffer A). Hearts were weighed,
aortae cannulated and retrograde/Langendorff perfusion (unload-
ed) was initiated with Buffer A equilibrated with 95% O2/5% CO2
at a pressure of 60 mmHg. Excess cardiac tissue was then
removed, the pulmonary artery cut, and the left atria cannulated.
Langendorff perfusion was then switched to loaded, aerobic,
working-mode perfusion and a micro-tip pressure catheter (Millar
instruments, Houston, Texas, USA) was forwarded into the left
ventricle (LV) with access via the left atrial cannula.
Experimental Protocol
To establish baseline conditions, hearts were perfused for
20 min in the aerobic, working mode. The experimental protocol
was then started only if LV developed pressure–heart rate (HR)
product was $23 (mmHg*beats*min21*1023). Global, no-flow
ischemia was initiated by clamping perfusate lines and placing the
heart in a tissue bath filled with substrate-free Buffer A gassed with
95% N2/5% CO2 at 32uC. An ischemic temperature of 32uC was
chosen as, at this temperature, increases in ischemic duration lead
to a less rapid decline in post-ischemic recovery versus ischemia at
37uC, permitting thus the precise generation of a broader range of
post-ischemic recoveries. Four different ischemic periods were
investigated: 30 min (n = 6), 50 min (n = 5), 55 min (n= 15) and
60 min (n = 5). A reperfusion period of 60 minutes followed, with
the initial 20 min in an unloaded-mode, with a constant aortic
pressure of 60 mmHg (Figure 1).
The loaded, aerobic perfusion condition was characterized by
an atrial filling pressure of 11.5 mmHg, an afterload-column set to
80 mmHg, with perfusion buffers maintained at 37uC and
oxygenated with 95% O2/5% CO2. From the establishment of
the working preparation, hearts were perfused only with recircu-
lating KH buffer supplemented with 1.2 mM palmitate, 3%
albumin; this includes the entire period of reperfusion, both
unloaded and loaded. More specifically, this buffer contained:
NaCl 118 mM, KCl 4.7 mM, KH2PO4 1.2 mM, MgSO4N7H2O
1.2 mM, CaCl2 1.25 mM, NaHCO3 25 mM, glucose 5.5 mM,
insulin 100 mIU/mL, albumin 3%, lactate 0.5 mM and palmitic
acid 1.2 mM (Buffer B); concentrations representing physiologic
levels of glucose, insulin and lactate and high levels of fatty acids.
High palmitate levels were chosen as circulating fatty acids are
typically elevated in humans undergoing cardiac surgery [19], and
are known to be detrimental to recovery of contractile function
following ischemia [20].
LV pressure curves and heart rate were continuously recorded
using a micro-tip pressure catheter (Millar instruments, Houston,
Tex) coupled to a high performance data acquisition system
(PowerLab, ADInstruments, Spechbach, Germany). Pressures
were analyzed at 10 and 20 min of aerobic perfusion and at 5,
10, 15, 20, 30, 40 and 60 min reperfusion. In order to reduce
variations in baseline drift associated with the micro-tip pressure
catheter, mean pre-ischemic left ventricular minimum pressure
was set to zero and subsequent pressure measurements were
adjusted correspondingly.
Coronary flow (CF) and aortic flow (AF) were measured by
timed collection at above-mentioned time-points (10 and 20 min
of pre-ischemic perfusion and at 5, 10, 15, 20, 30, 40 and 60 min
reperfusion). Samples of circulating buffer and coronary effluent
for quantification of markers of metabolism and necrosis were also
taken at these time points. Additional buffer samples for baseline
perfusate measurements were collected at the beginning of the pre-
ischemic working-mode and at the end of ischemia, immediately
before the initiation of reperfusion.
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Hemodynamics. The following hemodynamic parameters
were assessed:
N heart rate (HR [beats*min21]),
N peak systolic pressure (PSP [mmHg]),
N LV minimum pressure (Pmin [mmHg]),
N LV end-diastolic pressure (EDP [mmHg]),
N LV developed pressure (DP [PSP-Pmin; mmHg]),
N maximum and minimum first derivatives of LV pressure (dP/
dtmax and dP/dtmin [mmHg*s
21]),
N coronary flow (CF [mL*min21]),
N cardiac output (CO [CF+AF; mL*min21]), and
N LV work
- PSP-HR product [mmHg*beats*min21],
- DP-HR product [mmHg*beats*min21],
- triple product-PSP (TP(PSP) [PSP*dP/dtmax*HR;
mmHg2*beats*min21*s21]
- triple product-DP (TP(DP) [DP*dP/dtmax *HR;
mmHg2*beats*min21*s21]).
Markers of metabolism and necrosis. Lactate levels were
measured in buffer samples with an iSTAT analyzer (Abbott,
Baar, Switzerland) using CG4+ cartridges (Axonlab, Baden,
Switzerland). Lactate dehydrogenase (LDH) was assessed with a
Roche MODULAR P800 analyzer (Roche Diagnostics Corp,
Indianapolis, USA).
Predictive parameters. Predictive parameters were assessed
at 5 and 10 min reperfusion. Absolute and relative differences
between 5- and 10- min values were also analyzed. Predictive
parameters included all hemodynamic parameters mentioned
above, with the exception of cardiac output, as well as release of
lactate and lactate dehydrogenase.
Outcome parameters. Outcomes were measured at 60 min
reperfusion, and are presented as absolute value or as percent of
mean pre-ischemic value. Outcome parameters included all
hemodynamic parameters mentioned above.
Data Analysis
All values are expressed as mean6SD unless stated otherwise.
Data were analyzed using SPSS for Windows (version 17.0, SPSS
Inc, Chicago, Ill). Statistical analyses were performed using an
ANOVA with repeated measures for an overview of interactions
between ischemic group and measured parameters at baseline or
60 min reperfusion. Where significant overall results were
observed, comparisons between groups of particular interest were
performed using t-tests. Associations between outcome parameters
measured after 60 min reperfusion and predictive parameters at 5
and 10 min reperfusion were investigated using Spearman
correlations. Multiple linear regression analysis was used to
generate a composite, weighted predictive parameter based on
intraventricular pressure measurements. The predictive quality of
this composite parameter was examined using ROC analysis. All
p-values were two-sided, adjusted for multiple comparisons, and
reported after correction. Corrected p-values ,0.05 were consid-
ered statistically significant.
Results
Baseline Parameters
Thirty-one hearts were included in the study. Average pre-
ischemic characteristics of hearts are shown in Table S1. No
significant difference was observed between ischemic groups, with
the following exceptions: heart weight was significantly greater in
the 55-min and 60-min ischemic groups compared with the 30-
min ischemic group (p=0.033 and p=0.015, respectively); dP/
dtmax was significantly lower in the 55-min ischemic group
compared with the 30- min ischemic group (p=0.015) and
TP(PSP)/TP(DP) was significantly lower in the 55-min ischemic
group compared with the 30- min ischemic group (p=0.015).
Post-ischemic Cardiac Function
Hemodynamic function measured 60 min after reperfusion was
progressively reduced with increasing ischemic times (Figure 2).
Importantly, when considering all ischemic groups together after
60 min reperfusion, hemodynamic data, expressed as percentage
of pre-ischemic values, covered almost the entire range of
functional recovery. For instance, HR*PSP and HR*DP values
ranged from approximately 5–90% of pre-ischemic measure-
ments, while a range of approximately 0.5–60% recovery was
observed for HR*PSP*dP/dtmax and HR*DP*dP/dtmax (Table 1).
Early Reperfusion Predictive Parameters
For several parameters assessed at 5 and/or 10 min of unloaded
reperfusion, significant correlations were found with functional
outcome parameters recorded during the subsequent loaded
reperfusion phase (60 min reperfusion). A greater number of early
reperfusion parameters were found to correlate with outcomes
when assessed at 10 min versus 5 min or versus 5- to 10-min
absolute and relative changes, with the exception of LDH release
Figure 1. Perfusion protocol. Hearts (n = 31) were perfused for 20 min in aerobic working-mode, followed by global, no-flow ischemia. Four
different ischemic periods at 32uC were investigated: 30 min (n = 6), 50 min (n = 5), 55 min (n = 15) and 60 min (n = 5). Hearts were then reperfused
for 60 min, with the first 20 min in an unloaded-mode.
doi:10.1371/journal.pone.0043642.g001
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(data not shown). As such, apart from LDH release, early
reperfusion parameters are presented for the 10-min reperfusion
time-point only. Examples of correlations between hemodynamic
predictive parameters, and the outcome of HR*DP at 60-min
reperfusion are presented in Figure S1. An overview of the
correlations between ‘‘predictive’’ and ‘‘outcome’’ parameters is
given in Figure 3. Predictive parameters of particular interest are
presented in more detail in Table 2.
Hemodynamics. Predictive parameters of dP/dtmax, dP/
dtmin, Pmin, EDP and LV work (measured as HR*DP, TP(PSP)
and TP(DP)), all assessed after 10 min of unloaded reperfusion,
strongly correlated (p,0.001) with all eight LV work outcome
parameters (evaluated at 60 min reperfusion and expressed as
percent pre-ischemic and absolute values; Figure 3). Of particular
note, all Rho values for correlations with the eight LV work
outcome parameters were greater than 0.7 for the predictors
Figure 2. Post-ischemic contractile recovery. Functional recovery at 60 min reperfusion in hearts subjected to various periods of ischemia at
32uC. A) Heart rate (HR) - developed pressure (DP) product B) HR - DP - dP/dtmax product C) HR - peak systolic pressure product.
doi:10.1371/journal.pone.0043642.g002
Table 1. Hemodynamic parameters after 60 minutes reperfusion.
Ischemic group
30 minutes (n=6) 50 minutes (n =5) 55 minutes (n =15) 60 minutes (n=5)
% Abs 60’R % Abs 60’R % Abs 60’R % Abs 60’R
HR [beats*min21] 118624 264624 88624 204655 66624b 163662b 40623a 100657a
PSP [mmHg] 7869.9 10069 68629 85639 49626 57632 22613b 24614b,c
Pmin [mmHg] – 5.067.4 – 5.462.9 – 7.164.6 – 14.0610
EDP [mmHg] 1666126 1168 173643 1162 188674 1264 2536204 16610
DP [mmHg] 7468 9565.5 64631 80642 43629 50636 9.264.0b,c 1064.3b,c
dP/dtmax [mmHg*s
21] 68617 29716457 63631 241761306 45629 14756963 1065a,c 3226137b,c
dP/dtmin [mmHg*s
21] 7368.7 221626220 54628 217986966 36624a 211066751 1064.3b,c 22826113a,c
HR*PSP [mmHg*beats*min21*1023] 91616 26.564.6 63635 18.0610 34623b 9.9366.9b 6.862.2b,d 1.9360.65b,c
HR*DP [mmHg*beats*min21*1023] 86614 25.263.7 59636 17.0610.5 31623b 8.8667.0b 3.061.4b,d 0.85460.38b,d
TP (PSP) [mmHg2*beats*min21*s21*1026] 62618 80.4625 47632 53.5642 21618b 20.1618b 0.660.2b,c 0.56460.13b,c
TP (DP) [mmHg2*beats*min21*s21*1026] 59616 76.2622 46631 51.2640 20617b 18.8617b 0.360.1b,c 0.25560.11b,c
Cardiac output [mL*min21] 52619 2367 48632 30620 24618 12610 1266a 6.063.1c
Coronary flow [mL*min21] 75624 1464 81651 24617 50639 12610 21611 6.063.1
Data expressed as mean6SD.
ap,0.05 vs 30-minute ischemic value;
bp,0.01 vs 30-minute ischemic value;
cp,0.05 vs 50-minute ischemic value;
dp,0.01 vs 50-minute ischemic value;
DP: Developed pressure; EDP: LV end-diastolic pressure; HR: Heart rate; Pmin: Minimum LV pressure; PSP: Peak systolic pressure; TP (DP): Triple product (DP); TP (PSP):
Triple product (PSP).
doi:10.1371/journal.pone.0043642.t001
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HR*DP, TP(DP) and dP/dtmax; ranging from 0.72 to 0.79
(Table 2).
Coronary perfusion. ENREF_28CF measured at 10 min
reperfusion correlated with several outcomes, including all eight
measures of LV work, with Rho values ranging between 0.46 and
0.50 (p,0.05; Table 2 and Figure 3).
Markers of metabolism and necrosis. Lactate production
was not detectable in any of the hearts during the initial 20 min of
pre-ischemic, aerobic perfusion (data not shown). During reper-
fusion, however, a measurable increase in lactate production was
observed in the circulating buffer and in the coronary effluent of
all hearts. A negative correlation was found between lactate
production assessed at 10 min reperfusion and four outcome
Figure 3. Spearman correlations between predictive and outcome parameters. All predictive parameters were measured at 10-min
reperfusion except for LDH, which was calculated as percent change between 5- and 10-min reperfusion. Outcome parameters were measured at 60-
min reperfusion and either taken as absolute value (60’) or percentage of mean pre-ischemic value (%).
doi:10.1371/journal.pone.0043642.g003
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measures of LV work at 60 min reperfusion (HR*PSP – absolute
value, HR*DP– percentage pre-ischemic and absolute values, and
TP(DP) – percentage pre-ischemic value); with Rho values
between 20.56 and 20.63 (Table 2 and Figure 3).
The percentage change of LDH released between 5 and 10 min
reperfusion was negatively correlated with five outcome measures
of LV work at 60 min reperfusion (HR*PSP – percentage pre-
ischemic and absolute values, HR*DP – percentage pre-ischemic
and absolute values, and TP(DP) – percentage pre-ischemic value);
with Rho values between20.55 and20.62 (Table 2 and Figure 3).
Predictive quality. Multiple, linear regression analysis was
used to generate a weighted, composite predictor using predictive
parameters EDP and HR*DP and absolute 60-min reperfusion
HR*DP values as outcome (choice of predictive parameters based
on Spearman correlation analysis and on the logical complemen-
tarity of parameters; the former representing LV compliance, and
the latter representing LV work). The following relationship was
obtained:
Estimated HR*DP(60’ reperfusion) = 1.082*(HR*DP(10’ reperfusion))
2320.114*(EDP(10’ reperfusion)) +8.245*103.
This composite predictor was then evaluated using ROC
analysis using the following event threshold 60-minute HR*DP
cut-off values: $8*103; $10*103; $15*103; and $20
*103 mmHg*beats*min21 (Figure 4). Effective discriminating
ability was observed for all event cut-off values, and particularly
for the threshold of $20 *103 mmHg*beats*min21.
Discussion
In the present study, we have identified hemodynamic and
biochemical parameters that appear highly predictive regarding
the chances of myocardial contractile recovery after prolonged
ischemia. Most importantly, the correlation with functional
recovery could be established almost immediately after a simple
brief period of unloaded retrograde ex-vivo reperfusion. This
approach has the potential to be particularly useful in a clinical
setting of heart transplantation from NHBDs, as these measure-
ments can be obtained rapidly (10 minutes after end of ischemia),
are not technically challenging, and require little specialized
equipment. Furthermore, in the context of NHBDs, most
traditionally used means to assess suitability of the graft for
transplantation, such as echocardiography and/or coronary
angiography, may not be applicable. Our approach may therefore
serve as a first step towards the development of a clinical protocol
to evaluate the extent of warm ischemic damage and, consequent-
ly, to reliably predict the prognosis once the graft is transplanted
and reperfused (Figure 5).
Given that NHBDs are generally not considered as a source of
donor organs for cardiac transplantation due to tissue damage
caused by variable warm periods of ischemia [4], the importance
of a safe and reliable technique to test for heart eligibility is
evident. Ideally, methods to evaluate suitable donor hearts should
be easily and rapidly performed, and in accordance with ethical
and cultural concerns in the context of cardiac transplantation
from NHBDs. As such, we propose the assessment of heart
suitability for transplantation with use of a retrograde coronary
perfusion, immediately following the obligatory hands-off period at
the time of procurement. This type of perfusion approach is easy
to establish in either an ex vivo or an in situ configuration, and
allows immediate evaluation of the graft. In the case of a result
predicting suitability for transplantation, administration of cardio-
protective agents for cardioplegic storage, organ transport and
transplantation can be performed immediately thereafter.
This approach is not necessarily limited to NHBDs; it could
potentially serve as a useful tool to evaluate function of any cardiac
graft prior to transplantation. In fact, not only hearts from NHBDs
are exposed to a damaging environment, i.e. warm ischemia and
associated consequences. Indeed, hearts from brain-dead donors
are also often subjected to hemodynamic instability. This
Table 2. Rho values for statistically significant predictor-outcome correlationsa.
Outcome parameters [Rho]
Predictive Parameters HR*PSP HR*PSP HR*DP HR*DP TP (DP) TP (DP) TP (DP) TP (DP)
(%) (60’ R) (%) (60’) (%) (60’R) (%) (60’R)
Heart rate 10’ 0.507 0.485 0.554 0.539 0.568 0.502 0.543 0.500
Pmin 10’ 20.660 20.635 20.729 20.688 20.653 20.656 20.681 20.675
EDP 10’ 20.644 20.614 20.710 20.663 20.642 20.638 20.670 20.659
DP 10’ 0.597 0.617 0.603 0.624 0.607 0.635 0.593 0.623
dP/dtmax 10’ 0.718 0.728 0.732 0.732 0.743 0.744 0.733 0.749
dP/dtmin 10’ 20.606 20.627 20.621 20.636 20.650 20.677 20.630 20.681
HR*PSP 10’ 0.580 0.580 0.585 0.596 0.625 0.592 0.618 0.618
HR*DP 10’ 0.748 0.747 0.767 0.773 0.792 0.759 0.787 0.784
TP (PSP) 10’ 0.695 0.698 0.703 0.713 0.739 0.718 0.728 0.738
TP (DP) 10’ 0.729 0.733 0.753 0.757 0.771 0.751 0.767 0.771
Coronary flow 10’ 0.471 0.470 0.458 0.463 0.500 0.496 0.496 0.502
Lactate production 10’ NS 20.583 20.632 20.605 20.620 20.559 20.615 20.576
LDH release %-change 20.608 20.591 20.623 20.586 20.605 20.554 20.598 NS
Data are expressed as Rho. Rho: Spearman’s rank correlation coefficient;
aAll Rho values correspond to statistically significant correlations, for p-values see Figure 3; Outcome parameters: %: 60-min reperfusion value as percent of mean pre-
ischemic values; 60’R: value measured at 60-min reperfusion; Predictive parameters: 10’: Measurement at 10-min reperfusion; %-change: percentage change between 5-
and 10-min reperfusion values; DP: developed pressure; EDP: LV end-diastolic pressure; HR: heart rate; LDH: Lactate dehydrogenase; NS: Not significant; Pmin: LV
minimum pressure; PSP: LV peak systolic pressure; TP (DP): triple product (DP) – HR*DP*dP/dtmax; TP (PSP): triple product (PSP) – HR*PSP*dP/dtmax.
doi:10.1371/journal.pone.0043642.t002
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hemodynamic instability may lead to cardiac damage and/or
require pharmacological management that subsequently precludes
heart donation [21,22]. Therefore, our protocol could also be used
towards a procedure for heart screening such that other marginal
donors may be thoroughly evaluated, potentially further increasing
donor organ availability.
In this study, we took advantage of a recently developed
approach to produce a series of hearts with a broad range of
hemodynamic function following ischemia and reperfusion. More
specifically, in a previous series of experiments, we were able to
demonstrate that a slight reduction of the heart temperature
(32uC), initiated immediately after cardio-circulatory arrest, was
able to prolong ischemic tolerance (data not shown). Following
ischemia at 32uC, hearts recovered substantial hemodynamic
function after 50–55 minutes, whereas functional recovery was
completely abolished after 30 minutes ischemia at 37uC. For the
current study we used a similar approach, which enabled us to
employ a broader range of ischemic times, permitting a more
precisely defined degree of post-ischemic contractile recovery.
In our experimental setting, we found that early reperfusion
measures of EDP, Pmin, dP/dtmax, dP/dtmin and LV work
(HR*DP, TP(PSP) and TP(DP)) were more strongly correlated
with outcome parameters compared with other hemodynamic
parameters, biochemical markers or coronary flow. Interestingly,
previously recognized parameters of cardiac recovery, such as
lactate release [23] and coronary flow [13,14] were less strongly
correlated, and correlated with fewer outcomes compared with
hemodynamic parameters in our model. Given these findings, we
generated a composite, weighted predictor using HR*DP and
EDP; parameters chosen for their strong correlations with LV
work outcomes and their complementarity (the former represent-
ing LV work, and the latter representing LV compliance). Our
novel predictive parameter provides statistically significant pre-
dictive value for discriminating amongst subsequent LV work
outcomes and thereby offers a promising approach towards
Figure 4. ROC analysis for composite predictive parameter. ROC analysis for a novel, composite hemodynamic-based predictive parameter of
functional recovery after ischemia based on early reperfusion measures of HR-DP product and EDP. Discriminating ability of this composite predictive
parameter was evaluated using absolute values of HR*DP (mmHg*beats*min21) with the following event threshold cut-off values: $8*103, $10*103,
$15*103, and $20 *103.
doi:10.1371/journal.pone.0043642.g004
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human cardiac graft evaluation prior to transplantation. Despite
this fact, our work has been performed exclusively in a rat model
and further investigation is clearly required before transposing this
composite predictor to a clinical setting. Nevertheless, we provide
evidence indicating that strong correlations can be established
between early, accurately measurable parameters and functional,
clinically relevant outcomes.
Indeed, in future studies, it will be critical to investigate the
importance of including additional complementary parameters,
such as biochemical measures, in graft evaluation. For example, a
multi-step protocol of heart evaluation could be developed, with
an initial estimation of graft suitability using hemodynamic
measures, followed by the integration of complementary param-
eters such as laboratory data in order to obtain a reliable, robust
and sensitive means of evaluation. Importantly, given that graft
evaluation is likely to require a ‘‘go’’ versus ‘‘no-go’’ decision, only
predictive parameters that can provide immediate results should
be considered. In addition, since organ procurement from NHBDs
cannot necessarily be anticipated, predictive parameters that
require highly specialized equipment or expertise should be
avoided, such that they can be measured easily and rapidly in most
centers. Furthermore, utility of predictive the parameters de-
scribed here should be validated in large animal transplantation
models, and potentially in ex vivo human heart preparations, prior
to the commencement of clinical trials.
Our study identifies a novel approach for evaluation of the
suitability of NHBD hearts for transplantation, providing a
promising tool for the development of a clinical protocol for the
use of NHBDs. However, many aspects including precise
procurement and donor treatment protocols, definition of cardiac
death and hands-off time, acceptability limits for warm ischemia,
identification of protective interventions, as well as legal and
ethical issues must be addressed before widespread adoption of
cardiac transplantation from NHBDs is likely to occur. Impor-
tantly, given that waiting-list mortality remains excessive, approx-
imately 17% in patients in the US [6,24], approaches directed
towards the use of hearts from NHBDs clearly warrant further
investigation.
Limitations
We consider this work to be an early step towards the routine
use of cardiac grafts from NHBDs, given that additional work is
required for the translation of this approach to the clinic. As
mentioned above, the predictive parameters described must be
validated in a larger heart model, as our experiments were
performed exclusively in rat hearts. Secondly, hearts were
perfused in the absence of blood, but with physiologic buffer.
As such, blood-associated events, such as modifications in
inflammatory processes or reactive oxygen species scavenging,
that occur during ischemia and reperfusion could not be taken
into account. Nevertheless, given that circulating fatty acid levels
are typically elevated in humans undergoing cardiac surgery
[19], and are known to be detrimental to recovery of contractile
function following ischemia [20], we perfused hearts in the
presence of high palmitate levels to better approximate the
clinical situation. Thirdly, it is possible that the use of ketamine/
xylasine altered baseline, pre-ischemic hemodynamic function
and consequently affected values for percentage recovery.
However, we believe that ketamine/xylasine was a good
anesthetic choice for this study, as we wished to avoid ischemic
pre-conditioning effects caused by alternative anesthetics, such as
volatile anesthetics or pentobarbital (severe respiratory depres-
sion). Finally, recovery after ischemia was limited to a period of
60 minutes. Therefore, the validity of our predictive parameters
remains to be investigated with subacute and long-term recovery,
as well as following cardioplegic storage.
Figure 5. Schematic representation of NHBD-heart procurement/evaluation/transplantation process in a potential clinical scenario.
Following a precipitating event (e.g. trauma accident, removal of life-support) leading to cardio-circulatory arrest, the heart is subjected to a variable
period of warm ischemia and an obligatory hands-off period. Once invasive interventions are permitted, we propose that the heart could first be
reperfused in situ or ex vivo in an unloaded manner for 10 minutes, during which time predictive parameters could be measured for graft evaluation.
Immediately following this 10-minute period, and in the event that evaluation predicts a positive outcome, cardioplegia could be commenced and
the heart prepared for transport.
doi:10.1371/journal.pone.0043642.g005
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Supporting Information
Figure S1 Associations between predictive and outcome
parameters. Example associations between hemodynamic
parameters during early unloaded reperfusion and functional
outcome after 60 minutes reperfusion. Heart rate-developed
pressure product measured after 60 minutes reperfusion positively
correlated with A) dP/dtmax, B) Heart rate - developed pressure
product and C) Heart rate - developed pressure - dP/dtmax
product, all measured at 10 minutes reperfusion.
(TIFF)
Table S1 Baseline (pre-ischemic) characteristics. Data
expressed as mean6SD. *p,0.05 vs. 30 min ischemia group; DP:
Developed pressure; EDP: LV end-diastolic pressure; HR: Heart
rate; PSP: Peak systolic pressure; TP (DP): Triple product (DP); TP
(PSP): Triple product (PSP)
(DOC)
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